Intrinsiqs

Is Cencora, Inc. overvalued?

Cencora, Inc. (COR) looks overvalued — trading about 54% above its fair value.

Overvalued
Current price $359.03 Fair value $164.48
Price
$359.03
Fair value
$164.48
Current P/E
45.1
Normal P/E
20.7
Market cap
$68.51B
Dividend yield
0.7%
Return on equity
115.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares COR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.